During the last session, Sutro Biopharma Inc (NASDAQ:STRO)’s traded shares were 0.47 million, with the beta value of the company hitting 1.08. The 52-week high for the STRO share is $6.13, that puts it down -79.24 from that peak though still a striking 41.23% gain since the share price plummeted to a 52-week low of $2.01. The company’s market capitalization is $263.07M, and the average trade volume was 997.17K shares over the past three months.
Sutro Biopharma Inc (NASDAQ:STRO) trade information
The stock’s 5-day price performance is -5.79%, and it has moved by -30.63% in 30 days. Based on these gigs, the overall price performance for the year is -22.62%.
Sutro Biopharma Inc (STRO) estimates and forecasts
Statistics show that Sutro Biopharma Inc has underperformed its competitors in share price, compared to the industry in which it operates. Sutro Biopharma Inc (STRO) shares have gone up 21.28% during the last six months, with a year-to-date growth rate less than the industry average at -64.92% against 12.90. In the rating firms’ projections, revenue will decrease -63.70% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 11.92M as predicted by 9 analyst(s). Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to 22.51M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 12.67M and 10.41M respectively. In this case, analysts expect current quarter sales to shrink by -5.90% and then jump by 116.20% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 21.96%. While earnings are projected to return -101.38% in 2024, the next five years will return -12.88% per annum.
STRO Dividends
Sutro Biopharma Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
